Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Treasury Shares (2016 - 2026)

Champions Oncology has reported Treasury Shares over the past 12 years, most recently at $708000.0 for Q1 2026.

  • Quarterly results put Treasury Shares at $708000.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Jan 2026 was $708000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $708000.0, changed 0.0%.
  • Treasury Shares for Q1 2026 was $120333.0 at Champions Oncology, roughly flat from $120333.0 in the prior quarter.
  • Over the last five years, Treasury Shares for CSBR hit a ceiling of $120333.0 in Q1 2024 and a floor of $4896.0 in Q4 2023.
  • Median Treasury Shares over the past 4 years was $120333.0 (2024), compared with a mean of $100277.5.
  • Peak annual rise in Treasury Shares hit 856.76% in 2024, while the deepest fall reached 0.0% in 2024.
  • Champions Oncology's Treasury Shares stood at $708000.0 in 2023, then changed by 0.0% to $708000.0 in 2024, then changed by 0.0% to $708000.0 in 2025, then changed by 0.0% to $708000.0 in 2026.
  • The last three reported values for Treasury Shares were $708000.0 (Q1 2026), $708000.0 (Q4 2025), and $708000.0 (Q3 2025) per Business Quant data.